4//SEC Filing
Milanova Tsveta 4
Accession 0001439222-25-000002
CIK 0001439222other
Filed
Jan 6, 7:00 PM ET
Accepted
Jan 7, 5:05 PM ET
Size
8.9 KB
Accession
0001439222-25-000002
Insider Transaction Report
Form 4
Milanova Tsveta
Chief Commercial Officer
Transactions
- Sale
Common stock
2025-01-06$32.18/sh−2,804$90,233→ 18,906 total - Exercise/Conversion
Restricted stock units
2025-01-03−8,476→ 8,475 total→ Common stock (8,476 underlying) - Exercise/Conversion
Common stock
2025-01-03+8,476→ 21,710 total
Footnotes (3)
- [F1]Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated January 3, 2023.
- [F2]Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
- [F3]The restricted stock units were granted on January 3, 2023. Beginning on January 3, 2024, the shares underlying the restricted stock units will vest in three equal annual installments.
Documents
Issuer
AGIOS PHARMACEUTICALS, INC.
CIK 0001439222
Entity typeother
Related Parties
1- filerCIK 0001957180
Filing Metadata
- Form type
- 4
- Filed
- Jan 6, 7:00 PM ET
- Accepted
- Jan 7, 5:05 PM ET
- Size
- 8.9 KB